Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, November 11 at 2:00 PM ET

Register Free →

This Solicitation opportunity from Department Of Health And Human Services was posted on August 7, 2026. The submission period has ended. Browse the details below for market research, or find similar active opportunities.

Pharmacokinetic (PK) studies for RXFP1-agonists

Awarded
75N98026Q00976Federal

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

Active Opportunities Like This One

AI Contract Overview

Show more

The National Institutes of Health, Office of the Director, Office of Acquisitions, is soliciting proposals for pharmacokinetic studies for RXFP1-agonists under a firm-fixed-price contract through a competitive combined synopsis and solicitation issued in accordance with FAR Subpart 12.6. The solicitation number is 75N98026Q00976, and it is open to full and open competition without any set-aside provisions, targeting commercial services under the NAICS code 541380 for Testing Laboratories and Services, with a small business size standard of $19.0 million. Proposals must be submitted by the deadline of August 24, 2026, and the acquisition is structured to ensure best value to the government without exceeding the simplified acquisition threshold. The solicitation incorporates all applicable provisions and clauses in effect as of August 7, 2026, and is not followed by a separate written document. Performance location is not specified beyond the agency’s address in Bethesda, Maryland. Points of contact for inquiries include Johnstion, Jaddua C, with email and phone details provided. The procurement is unrestricted and intended for commercial services that meet the government's pharmacokinetic testing requirements for RXFP1-agonist compounds.

General Info

NIH seeks commercial pharmacokinetic studies for RXFP1-agonists via firm-fixed-price contract until August 24, 2026.

Contract Value

$19,296

NAICS

541380 - Testing Laboratories and Services

Place of Performance

MD, USA

Set-Aside

NONE

Award Issued Date

Documents

1

RFQ 75N98026Q00976 Pharmacokinetic Studies for RXFP1-Agonists

PDF, High priority: read this firstrfq
High

AI Contract Breakdown

Uniform Contract Format

Sign up to view the full breakdown with detailed analysis of each section.

Timeline

PhaseAwarded
Posted

Solicitation

Awarded

Contract was awarded

Submission Closed

Find active opportunities like this

Get full access to discover similar active contracts, track opportunities, and build proposals with AI assistance.

Organization & Contact Information

Show more
AgencyDepartment Of Health And Human Services → National Institutes Of Health Olao
Contacts1 person available
OfficeBETHESDA, MD, 20892, USA
Office AddressBETHESDA, MD, 20892, USA
Contacts

Full Description

Show more
(i) This is a combined synopsis/solicitation for commercial items prepared in accordance with FAR Subpart 12.6, as supplemented with additional information included in this notice. This announcement constitutes only solicitation; proposals are being requested, and a separate written solicitation will not be issued.

(ii) The solicitation number is 75N98026Q00976. This solicitation is issued as a competitive combined synopsis/solicitation for commercial products or commercial services. The Government intends to award a contract or purchase order resulting from this solicitation using full and open competition.

This acquisition is conducted under the authority of FAR 12.603, Streamlined Solicitation for Commercial Products or Commercial Services, and is not expected to exceed the simplified acquisition threshold (if applicable).

The National Institutes of Health (NIH), Office of the Director, Office of Acquisitions, seeks to award a (Firm-Fixed-Price) to the offeror responsible whose proposal represents the best value to the Government.

(iii) The solicitation document and incorporated provisions and clauses are those in effect through Federal Acquisition Circular effective August 7, 2026

(iv) The associated NAICS code is 541380 Testing Laboratories and Services, and the small business size standard is $19.0 million.

This requirement is unrestricted.

More opportunities from Department Of Health And Human Services → National Institutes Of Health Olao

Same awarding agency

Earlier notices in this NAICS code

Posted before this notice, open and closed

Find Active Opportunities Like This

Get AI-powered intelligence on the opportunities still open

Every page of the solicitation package shredded into a compliance breakdown

AI-powered matching based on your capabilities and past performance

Competitor and incumbent history on the requirement

Automated alerts on amendments, Q&A deadlines, and award

Miguel
Hillary
Keith Deutsch
Christine

Join 750+ contractors already using CLEATUS